475 related articles for article (PubMed ID: 19593974)
21. Argon plasma coagulation is an effective treatment for hereditary hemorrhagic telangiectasia patients with severe nosebleeds.
Pagella F; Matti E; Chu F; Pusateri A; Tinelli C; Olivieri C; Canzonieri C; Boeri L; Ornati F; Danesino C
Acta Otolaryngol; 2013 Feb; 133(2):174-80. PubMed ID: 23066781
[TBL] [Abstract][Full Text] [Related]
22. Embolization of pulmonary arteriovenous malformations and decrease in prevalence of migraine.
Post MC; Thijs V; Schonewille WJ; Budts W; Snijder RJ; Plokker HW; Westermann CJ
Neurology; 2006 Jan; 66(2):202-5. PubMed ID: 16434654
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of epistaxes in hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease) with tranexamic acid].
Morales-Angulo C; Pérez del Molino A; Zarrabeitia R; Fernández A; Sanz-Rodríguez F; Botella LM
Acta Otorrinolaringol Esp; 2007 Apr; 58(4):129-32. PubMed ID: 17428407
[TBL] [Abstract][Full Text] [Related]
24. Cauterization for epistaxis in hereditary hemorrhagic telangiectasia.
Dabiri J; Fakhoury R; Choufani G; Mine B; Hassid S
B-ENT; 2016; 12(1):9-16. PubMed ID: 27097388
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous embolization for control of nasal blood circulation.
Parnes LS; Heeneman H; Vinuela F
Laryngoscope; 1987 Nov; 97(11):1312-5. PubMed ID: 2823032
[TBL] [Abstract][Full Text] [Related]
26. The Young's procedure for severe epistaxis from hereditary hemorrhagic telangiectasia.
Richer SL; Geisthoff UW; Livada N; Ward PD; Johnson L; Mainka A; Henderson KJ; Maune S; White RI; Ross DA
Am J Rhinol Allergy; 2012; 26(5):401-4. PubMed ID: 23168156
[TBL] [Abstract][Full Text] [Related]
27. A silicone nasal swab for the treatment of severe and recalcitrant epistaxis in hereditary hemorrhagic telangiectasia: an alternative to surgical nostril closure.
Bruschini L; Seccia V; Dallan I
Am J Otolaryngol; 2011; 32(4):301-3. PubMed ID: 20719406
[TBL] [Abstract][Full Text] [Related]
28. Treatment of severe epistaxis by superselective embolization: a review of 22 cases.
Ricci G; Molini E; Hamam M; Ciorba A; Altissimi G; Campanella S; Fiacca A; Pelliccioli G
Rev Laryngol Otol Rhinol (Bord); 2004; 125(4):247-51. PubMed ID: 15712697
[TBL] [Abstract][Full Text] [Related]
29. Epistaxis in hereditary haemorrhagic telangiectasia.
Haitjema T; Balder W; Disch FJ; Westermann CJ
Rhinology; 1996 Sep; 34(3):176-8. PubMed ID: 8938889
[TBL] [Abstract][Full Text] [Related]
30. Endovascular treatment of epistaxis: indications, management, and outcome.
Strach K; Schröck A; Wilhelm K; Greschus S; Tschampa H; Möhlenbruch M; Naehle CP; Jakob M; Gerstner AO; Bootz F; Schild HH; Urbach H
Cardiovasc Intervent Radiol; 2011 Dec; 34(6):1190-8. PubMed ID: 21472510
[TBL] [Abstract][Full Text] [Related]
31. [Treatments of hereditary hemorrhagic telangiectasia of the nasal mucosa].
Babin E; Borsik M; Braccard S; Crampette L; Darrouzet V; Faure F; Fontanel JP; Houdart E; Jankowski R; Le Clech G; Malvezzi L; Morinière S; Perie S; Perret J; Pignat JC; Portier F; Serrano E; Plauchu H
Rev Laryngol Otol Rhinol (Bord); 2005; 126(1):43-8. PubMed ID: 16080648
[TBL] [Abstract][Full Text] [Related]
32. A grading scale for epistaxis in hereditary haemorrhagic teleangectasia.
Al-Deen S; Bachmann-Harildstad G
Rhinology; 2008 Dec; 46(4):281-4. PubMed ID: 19145996
[TBL] [Abstract][Full Text] [Related]
33. Lifestyle and dietary influences on nosebleed severity in hereditary hemorrhagic telangiectasia.
Silva BM; Hosman AE; Devlin HL; Shovlin CL
Laryngoscope; 2013 May; 123(5):1092-9. PubMed ID: 23404156
[TBL] [Abstract][Full Text] [Related]
34. Are patients with severe epistaxis caused by hereditary hemorrhagic telangiectasia satisfied with nostril closure surgery?
Ichimura K; Kikuchi H; Imayoshi S; Yamauchi T; Ishikawa K
Auris Nasus Larynx; 2012 Feb; 39(1):59-64. PubMed ID: 21592697
[TBL] [Abstract][Full Text] [Related]
35. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose.
Dheyauldeen S; Østertun Geirdal A; Osnes T; Vartdal LS; Dollner R
Laryngoscope; 2012 Jun; 122(6):1210-4. PubMed ID: 22565282
[TBL] [Abstract][Full Text] [Related]
36. Endovascular treatment of epistaxis.
Vokes DE; McIvor NP; Wattie WJ; Chaplin JM; Morton RP
ANZ J Surg; 2004 Sep; 74(9):751-3. PubMed ID: 15379802
[TBL] [Abstract][Full Text] [Related]
37. Coblation for epistaxis management in patients with hereditary haemorrhagic telangiectasia: a multicentre case series.
Joshi H; Woodworth BA; Carney AS
J Laryngol Otol; 2011 Nov; 125(11):1176-80. PubMed ID: 21846415
[TBL] [Abstract][Full Text] [Related]
38. Morphology and distribution of nasal telangiectasia in HHT-patients with epistaxis.
Folz BJ; Wollstein AC; Lippert BM; Werner JA
Am J Rhinol; 2005; 19(1):65-70. PubMed ID: 15794077
[TBL] [Abstract][Full Text] [Related]
39. [Rendu-Osler disease. Follow-up of 6 patients treated by embolization. Nasal telecobaltotherapy in a refractory case].
Esparcia Navarro M; Ferrer Baixauli F; Moya Albiol S; Vento Torres D; García Callejo FJ; Soler Marquessins F; Marco Algarra J
Acta Otorrinolaringol Esp; 1999 Apr; 50(3):197-201. PubMed ID: 10362862
[TBL] [Abstract][Full Text] [Related]
40. Treatment of profuse epistaxis in patients irradiated for nasopharyngeal carcinoma.
Wong GK; Chan KK; Yu SC; Tsang RK; Poon WS
ANZ J Surg; 2007 Apr; 77(4):270-4. PubMed ID: 17388834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
